DIPHENYLAN SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Diphenylan Sodium patents expire, and when can generic versions of Diphenylan Sodium launch?
Diphenylan Sodium is a drug marketed by Chartwell Molecular and is included in one NDA.
The generic ingredient in DIPHENYLAN SODIUM is phenytoin sodium. There are twenty-one drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the phenytoin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Diphenylan Sodium
A generic version of DIPHENYLAN SODIUM was approved as phenytoin sodium by HIKMA on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DIPHENYLAN SODIUM?
- What are the global sales for DIPHENYLAN SODIUM?
- What is Average Wholesale Price for DIPHENYLAN SODIUM?
Summary for DIPHENYLAN SODIUM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 77 |
| Patent Applications: | 1 |
| DailyMed Link: | DIPHENYLAN SODIUM at DailyMed |
US Patents and Regulatory Information for DIPHENYLAN SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Molecular | DIPHENYLAN SODIUM | phenytoin sodium | CAPSULE;ORAL | 080857-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chartwell Molecular | DIPHENYLAN SODIUM | phenytoin sodium | CAPSULE;ORAL | 080857-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
